Violation Tracker Individual Record

Company: 
Galena Biopharma Inc.
Current Parent Company: 
SELLAS Life Sciences Group
Penalty: 
$7,550,000
Year: 
2017
Date: 
September 8, 2017
Offense Group: 
government-contracting-related offenses
Primary Offense: 
False Claims Act and related
Secondary Offense: 
kickbacks and bribery
Violation Description: 

Galena Biopharma Inc. agreed to pay more than $7.55 million to resolve allegations that it paid kickbacks to doctors to induce them to prescribe its fentanyl-based drug Abstral. The allegations arose from a whistleblower suit filed under the False Claims Act.

Level of Government: 
federal
Action Type: 
agency action
Agency: 
U.S. Attorney-District of New Jersey
Civil or Criminal Case: 
civil
HQ Country of Parent: 
USA
HQ State of Parent: 
New York
Ownership Structure of Parent: 
publicly traded
Major Industry of Parent: 
pharmaceuticals
Specific Industry of Parent: 
pharmaceuticals
Source Notes: 
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note: 
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.